Mesoblast Limited (ASX:MSB – Get Free Report) insider Eric Rose bought 21,428 shares of the firm’s stock in a transaction that occurred on Tuesday, April 30th. The shares were acquired at an average cost of A$6.64 ($4.40) per share, for a total transaction of A$142,324.78 ($94,254.82).
Mesoblast Price Performance
The company has a debt-to-equity ratio of 23.98, a quick ratio of 1.82 and a current ratio of 2.71.
Mesoblast Company Profile
Featured Stories
- Five stocks we like better than Mesoblast
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- 3 REITs to Buy and Hold for the Long Term
- Generac Powers Ahead on the Electrification Mega-Trend
- Why Invest in Biotech Stocks
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.